Founder interview
“What challenge does Dynamic42 solve? What is our vision?” or “What have been our greatest successes?” are just some of the questions we answered in the interview with bionity and analytica-world. Read the complete interview at analytica-world or bionity.
In addition, we at bionity can now also be found in the start-up directory:
Read now more News:
News
Press Release | Ohio Lumex Named Exclusive U.S. Distributor for Dynamic42’s Advanced Organ-on-Chip Technology
Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.
Read MoreNews
Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer
Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.
Read MoreNews
Press Release | Dynamic42 and research partners present three-organ system to reduce animal testing
Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.
Read More